Study guide
15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration
Neonatal Pediatric Transport C-NPT
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The C-NPT Exam
About the C-NPT Exam: 2026 Format, Eligibility & Content Outline
2 Chapter 1: Transport Systems, Regulatory Framework & Legal Issues
1.1 Transport System Architecture, Accreditation (CAMTS) & Dispatch Triage 1.2 Regulatory & Legal Mandates: EMTALA, HIPAA, Consent & Documentation 1.3 Medical Direction, Scope of Practice & Ethical Considerations
3 Chapter 2: Safety, Communication, Crew Resource Management & Transport Environment
2.1 Crew Resource Management (CRM), Situational Awareness & Sterile Cockpit 2.2 Aircraft & Ground Ambulance Operations, Landing Zones & Vehicle Dynamics 2.3 Environmental Hazards, Weather Minimums & In-Flight Emergency Procedures 2.4 Communication in Transport: Peer Handoffs, Age-Appropriate Care, Families & Crew Stressors 2.5 Infection Control, PPE, Scene Safety & Disaster/Evacuation Planning
4 Chapter 3: Flight Physiology & Environmental Stressors
3.1 Physical Gas Laws & Transport Implications (Boyle, Dalton, Charles, Henry, Graham) 3.2 Altitude Hypoxia, Barometric Pressure Changes & Dysbarism 3.3 Acceleration Forces (G-forces), Vibration & Acoustic Stress in Transit 3.4 Thermoregulation Physics & Neutral Thermal Environment in Transit
5 Chapter 4: Invasive Procedures & Transport Monitoring
4.1 Advanced Airway Management & Endotracheal Intubation in Transit 4.2 Pleural Decompression (Needle Thoracostomy & Chest Tube Management) 4.3 Vascular Access: Umbilical Lines (UAC/UVC), Intraosseous (IO) & Arterial Lines
6 Chapter 5: Transport Equipment, Respiratory Physiology & Mechanical Ventilation
5.1 Transport Incubators (Isolettes), Thermal Control & Electrical/Gas Power Systems 5.2 Portable Ventilators & Modes (PC, VC, PRVC, High Frequency) 5.3 Gas Cylinder Duration Calculations, Oxygen Delivery & Inhaled Nitric Oxide (iNO) 5.4 Respiratory Physiology: Acid-Base Balance, Oxygenation, Lung Mechanics & Troubleshooting
7 Chapter 6: Transport Pharmacology, Resuscitation, Fluids & Electrolytes
6.1 Vasoactive Infusions & Inotropes (Epinephrine, Dopamine, Dobutamine, Milrinone) 6.2 Sedation, Analgesia & Neuromuscular Blockade in Transport 6.3 Prostaglandin E1 (Alprostadil) & Surfactant Replacement Therapy 6.4 Resuscitation Protocols (NRP, PALS) & Shock Fluid Resuscitation 6.5 Antimicrobial Pharmacology in Neonatal & Pediatric Transport 6.6 Post-Resuscitation Care, Defibrillation & Cardioversion in Transit, ECMO Indications & the Transport-vs-Stay Decision 6.7 Fluid & Electrolyte Therapy Across the Ages: Maintenance, Dehydration, Fluid Overload & Electrolyte Emergencies
8 Chapter 7: Neonatal Respiratory Pathologies & Management
7.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 7.2 Meconium Aspiration Syndrome (MAS) & Persistent Pulmonary Hypertension (PPHN) 7.3 Transient Tachypnea (TTN), Neonatal Pneumothorax & Congenital Diaphragmatic Hernia (CDH) 7.4 Neonatal Upper Airway Anomalies, Aspiration, Pneumonia, Chronic Lung Disease & Respiratory Failure
9 Chapter 8: Neonatal Cardiovascular Critical Care
8.1 Ductal-Dependent Cyanotic Congenital Heart Defects (TGA, TOF, Tricuspid Atresia) 8.2 Ductal-Dependent Systemic Blood Flow Lesions (HLHS, Coarctation, Interrupted Arch) 8.3 Neonatal Arrhythmias, Cardiogenic Shock & Post-Resuscitation Care 8.4 Acyanotic Congenital Heart Lesions, Patent Ductus Arteriosus, Obstructed TAPVR & Neonatal Heart Failure
10 Chapter 9: Neonatal Neurological & Metabolic Crises
9.1 Hypoxic-Ischemic Encephalopathy (HIE) & Passive/Active Therapeutic Hypothermia 9.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 9.3 Neonatal Hypoglycemia, Electrolyte Derangements & Hyperbilirubinemia 9.4 Subgaleal Hemorrhage, Neonatal Sepsis & Meningitis, and Perinatal Substance Exposure (NOWS)
11 Chapter 10: Neonatal Surgical Emergencies, Neural Tube Defects & ELBW Care
10.1 Abdominal Wall Defects (Gastroschisis vs. Omphalocele) & TEF/Esophageal Atresia 10.2 Necrotizing Enterocolitis (NEC), Malrotation with Volvulus & Intestinal Obstruction 10.3 Care of the Extremely Low Birth Weight (ELBW) Infant (<1000g) in Transit 10.4 Neural Tube Defects: Myelomeningocele, Encephalocele & Transport of the Newborn With an Open Spinal Defect
12 Chapter 11: Pediatric Respiratory Emergencies
11.1 Acute Upper Airway Obstruction (Croup, Epiglottitis, Bacterial Tracheitis, Foreign Body) 11.2 Lower Airway Crises: Status Asthmaticus & Severe Bronchiolitis 11.3 Pediatric Acute Respiratory Distress Syndrome (PARDS) & Severe Pneumonia
13 Chapter 12: Pediatric Shock & Cardiovascular Crises
12.1 Pathophysiology & Transport Management of Pediatric Septic Shock 12.2 Hypovolemic, Cardiogenic & Anaphylactic Shock in Children 12.3 Pediatric Cardiac Emergencies: SVT, Ventricular Arrhythmias & Myocarditis 12.4 Pediatric Cardiovascular Crises: Palliated Congenital Heart Disease, Pulmonary Hypertensive Crisis, Pericarditis & Tamponade, Hypertensive Emergency & Anterior Mediastinal Mass
14 Chapter 13: Pediatric Neurological Emergencies & Trauma
13.1 Status Epilepticus, Altered Mental Status & Meningitis/Encephalitis 13.2 Pediatric Traumatic Brain Injury (TBI) & Increased Intracranial Pressure (ICP) 13.3 Blunt/Penetrating Trauma, Spinal Motion Restriction & Thermal Burns 13.4 Non-Accidental Trauma, Smoke Inhalation (Carbon Monoxide & Cyanide) & Heat Illness
15 Chapter 14: Pediatric Toxicological, Environmental & Endocrine Emergencies
14.1 Common Pediatric Toxic Ingestions, Poisonings & Antidotes 14.2 Diabetic Ketoacidosis (DKA) & Environmental Emergencies (Submersion, Hypothermia) 14.3 Button Battery & Foreign-Body Ingestions, Bites & Envenomations, and Hazardous-Material Exposures
16 Chapter 15: Pediatric Metabolic & Hematologic Emergencies
15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration 15.2 Oncologic Emergencies, Acute Kidney Injury & Pediatric Electrolyte Crises
15.1 Anemia, Sickle Cell Disease, Coagulopathies & Blood Product Administration
Key Takeaways Explain This Topic AI
In sickle cell disease, a temperature of 38.5°C or higher is treated as an emergency with prompt blood culture and parenteral antibiotics such as ceftriaxone, because functional asplenia raises the risk of overwhelming infection.
Acute chest syndrome is a new pulmonary infiltrate with fever or respiratory symptoms in a child with sickle cell disease; treatment includes oxygen, antibiotics (a cephalosporin plus a macrolide), analgesia, incentive spirometry, and transfusion (exchange for severe cases).
Splenic sequestration causes a rapid hemoglobin drop with an enlarging spleen and hypovolemic shock; transfusion is given in small aliquots because trapped cells return to the circulation as the spleen releases them.
For life-threatening bleeding in hemophilia, factor replacement comes first, before imaging or procedures: about 50 IU/kg of factor VIII in hemophilia A, and a product-specific dose of factor IX (often about 100 IU/kg) in hemophilia B.
Packed red cells at 10–15 mL/kg typically raise hemoglobin by about 2–3 g/dL; blood is infused only with 0.9% saline, and suspected transfusion reactions are managed by stopping the transfusion and supporting the patient.
Last updated: September 2026
- Anemia, Sickle Cell Disease, Coagulopathies & Blood Products
- Anemia in the Transport Patient
Oxygen delivery equals cardiac output × arterial oxygen content, and oxygen content depends mostly on hemoglobin (Section 5.4). Children compensate for anemia with tachycardia and increased stroke volume, until they cannot.
Type Examples Transport concerns
Acute blood loss Trauma (Section 13.3), GI bleeding, subgaleal hemorrhage (Section 9.4) Hypovolemic shock; hemoglobin falls late; replace blood, not just crystalloid
Hemolysis Sickle cell crisis, G6PD deficiency with oxidant exposure, autoimmune hemolytic anemia, hemolytic uremic syndrome Hyperkalemia, hyperbilirubinemia, kidney injury; autoimmune hemolysis makes crossmatching difficult
Decreased production Iron deficiency, aplastic crisis (parvovirus B19), leukemia, bone marrow failure Often chronic and well compensated, but high-output heart failure can occur
Severe chronic anemia (for example, hemoglobin 3–4 g/dL from iron deficiency in a toddler with heavy cow's milk intake) causes compensated high-output circulation. A rapid large-volume transfusion can cause heart failure . Transfuse slowly in small aliquots (commonly about 5 mL/kg at a time), sometimes with a diuretic, while watching for pulmonary edema.
Altitude matters: Anemic patients have little oxygen reserve. Provide supplemental oxygen, and consider cabin altitude restrictions for severe anemia (Section 3.2).
Sickle Cell Disease (SCD) Emergencies
Deoxygenated hemoglobin S polymerizes. Red cells sickle, occlude microvessels, and hemolyze. Children with SCD develop functional asplenia early in life.
Emergency Key features Transport management
Fever Temperature ≥38.5°C (NHLBI threshold); high risk of pneumococcal and other encapsulated-organism sepsis Blood culture and prompt parenteral antibiotics (for example, ceftriaxone) without waiting for results; treat shock
Acute chest syndrome (ACS) New infiltrate on radiograph plus fever and/or respiratory symptoms (chest pain, cough, tachypnea, hypoxemia); can progress rapidly Oxygen to keep saturation normal, antibiotics (cephalosporin plus macrolide), analgesia (splinting from pain worsens atelectasis), incentive spirometry , cautious fluids (avoid overload), simple or exchange transfusion for severe or progressive disease
Vaso-occlusive pain crisis Severe pain in limbs, back, chest, or abdomen Rapid analgesia with parenteral opioids within about an hour of arrival (NHLBI), hydration without overload, monitor for ACS
Splenic sequestration Sudden pallor, weakness, enlarging spleen , hemoglobin drop of about 2 g/dL or more below baseline, hypovolemic shock; usually young children Volume resuscitation and careful transfusion in small aliquots ; as the spleen releases trapped cells, hemoglobin can rise more than expected (overshoot increases viscosity)
Aplastic crisis Parvovirus B19 halts red cell production; severe anemia with very low reticulocyte count Transfusion; droplet precautions (parvovirus is contagious to pregnant staff and other SCD patients)
Stroke Focal deficits, seizures, altered consciousness Exchange transfusion (target HbS below about 30%) at a specialty center; avoid delays; neuroimaging
Priapism Prolonged painful erection Analgesia, hydration, urology consultation (time sensitive)
Transport-specific points:
Hypoxemia promotes sickling. Give supplemental oxygen when saturation is low, and consider altitude effects during air transport.
Avoid hypothermia and dehydration , both of which promote sickling. Avoid overhydration, which worsens ACS.
Avoid raising hemoglobin above about 10 g/dL with simple transfusion, because high viscosity can trigger vaso-occlusion and stroke.
Transfused SCD patients need phenotypically matched blood when possible to prevent alloimmunization. Let the blood bank know the diagnosis.
- Coagulopathies
- Hemophilia
Hemophilia A (factor VIII deficiency) and hemophilia B (factor IX deficiency) are X-linked. They cause joint, muscle, and potentially life-threatening intracranial, airway (neck, tongue), and iliopsoas bleeding.
Factor first: For suspected intracranial hemorrhage or other life-threatening bleeding, give factor replacement before imaging or procedures:
Hemophilia A: about 50 IU/kg of factor VIII , which raises activity to roughly 100%
Hemophilia B: a product-specific dose of factor IX (plasma-derived products are often dosed at about 100 IU/kg for 100%)
Follow the patient's hematology plan and home product whenever available.
Avoid intramuscular injections, arterial punctures where possible, and NSAIDs.
Patients with inhibitors or on emicizumab prophylaxis need their hematology team's specific plan. Emicizumab also makes the aPTT unreliable.
Von Willebrand disease
The most common inherited bleeding disorder. Mucosal bleeding. Desmopressin (DDAVP) helps responsive types. Watch for hyponatremia after DDAVP, especially in young children. Factor concentrates containing von Willebrand factor are used for major bleeding.
Immune thrombocytopenia (ITP)
Sudden petechiae and bruising in a well-appearing child, often after a viral illness, with isolated thrombocytopenia. Life-threatening bleeding is rare. When it occurs (intracranial hemorrhage, severe GI bleeding), treat with IVIG and corticosteroids plus platelet transfusion . Platelets alone are consumed quickly. Avoid IM injections and contact activities.
Disseminated intravascular coagulation (DIC)
Consumption of clotting factors and platelets with microvascular thrombosis. It occurs in sepsis (especially meningococcemia with purpura fulminans), trauma, heat stroke, and malignancy. Treat the cause. Replace products for bleeding or before procedures: platelets, fresh frozen plasma , and cryoprecipitate for low fibrinogen.
Vitamin K deficiency bleeding (VKDB)
Newborns have low vitamin K stores. VKDB can cause GI, skin, and intracranial bleeding in the first weeks to months, especially in exclusively breastfed infants who did not receive vitamin K at birth (0.5–1 mg IM prophylaxis). Treat with IV or subcutaneous vitamin K and fresh frozen plasma (or prothrombin complex concentrate per protocol) for active bleeding. Always ask whether vitamin K was given.
Blood Product Administration in Transport
Product Typical pediatric dose Expected effect / notes
Packed red blood cells 10–15 mL/kg Raises hemoglobin about 2–3 g/dL; slower, smaller aliquots in chronic severe anemia
Platelets 10–15 mL/kg (or 1 unit per 10 kg of whole blood-derived platelets) Raises count roughly 50,000–100,000/mcL; less effective in ITP
- Fresh frozen plasma 10–15 mL/kg Replaces clotting factors
- Cryoprecipitate About 1 unit per 5–10 kg Fibrinogen, factor VIII, von Willebrand factor, factor XIII
Safety essentials:
Two-person identity check at the bedside, and verification of the product, expiration, and compatibility.
Only 0.9% saline runs with blood. Dextrose solutions cause hemolysis, and calcium-containing solutions (such as lactated Ringer's) can cause clotting with the citrate anticoagulant.
Use a blood filter , and a warmer for rapid or large-volume transfusion (Section 6.4).
Irradiated products prevent transfusion-associated graft-versus-host disease in at-risk patients (preterm neonates, intrauterine or exchange transfusions, immunodeficiency, 22q11 deletion). Leukoreduced (CMV-safe) products are standard for neonates.
Massive transfusion causes hypocalcemia (citrate), hyperkalemia (older units), hypothermia, and dilutional coagulopathy. Check ionized calcium and potassium.
Transfusion reactions: stop the transfusion first.
Reaction Clues Action
Acute hemolytic (ABO incompatibility) Fever, chills, hypotension, back or flank pain, hemoglobinuria, DIC; in sedated patients only hypotension and bleeding Stop, keep IV open with saline, support circulation, maintain urine output, notify the blood bank, return the unit
Febrile non-hemolytic Fever or chills without instability Stop, exclude hemolysis and bacterial contamination, antipyretic
Allergic or anaphylactic Urticaria, or bronchospasm and hypotension Antihistamine for mild; IM epinephrine for anaphylaxis
TRALI (transfusion-related acute lung injury) Hypoxemia and bilateral infiltrates within 6 hours, often with fever and hypotension Respiratory support; diuretics are not helpful
TACO (circulatory overload) Hypertension, pulmonary edema, and volume overload Stop or slow the transfusion, give diuretics, sit the patient up